Outlook Therapeutics' wet AMD therapy study results validates expectations, looks forward to Phase 3
Outlook Therapeutics, Inc. (NASDAQ:OTLK) CEO Lawrence Kenyon tells Proactive the clinical-stage biopharmaceutical company says its ONS-5010 therapy to treat wet AMD revealed positive proof-of-concept results.
Kenyon says investors should understand that this small, 60-patient clinical study was not expected to achieve statistical significance, however, its pivotal NORSE 2 pivotal trial will reveal these results.
Story by ProactiveInvestors
Source: https://www.proactiveinvestors.com/companies/news/927905/outlook-therapeutics--wet-amd-therapy-study-results-validates-expectations-looks-forward-to-phase-3-927905.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).